Chemosensitivity of human melanoma metastases in mouse subrenal capsule assay???can it predict tumour response to combined cytostatic plus interferon therapy in metastatic melanoma?

1996 ◽  
Vol 6 (3) ◽  
pp. 215-221 ◽  
Author(s):  
M Hahka-Kemppinen ◽  
T Muhonen ◽  
L Kangas ◽  
S Pyrh??nen
Keyword(s):  
Metastatic Melanoma ◽  
Interferon Therapy ◽  
Tumour Response ◽  
Human Melanoma ◽  
Subrenal Capsule Assay ◽  
Melanoma Metastases ◽  
Subrenal Capsule

Mouse Subrenal Capsule Assay Chemosensitivity and DNA Flow Cytometry Parameters of Human Melanoma Metastases

1994 ◽  
Vol 33 (4) ◽  
pp. 431-437 ◽  
Author(s):  
Timo Muhonen ◽  
Seppo Pyrhönen ◽  
Antero Laasonen ◽  
Veli-Matti Wasenius ◽  
Sirpa Asko-Seljavaara ◽  
...  
Keyword(s):  
Flow Cytometry ◽  
Human Melanoma ◽  
Dna Flow Cytometry ◽  
Subrenal Capsule Assay ◽  
Melanoma Metastases ◽  
Subrenal Capsule

The Subrenal Capsule Assay as a Predictor of Tumour Response in Gynaecological Oncology

1986 ◽  
pp. 9-15
Author(s):  
R. E. Hunter ◽  
T. W. Griffin ◽  
S. D. Reich ◽  
J. M. Price ◽  
A. E. Bogden
Keyword(s):  
Tumour Response ◽  
Subrenal Capsule Assay ◽  
Gynaecological Oncology ◽  
Subrenal Capsule

scholarly journals A New Role of Vemurafenib as a Neoadjuvant Treatment of Axillary and Brain Melanoma Metastases

2013 ◽  
Vol 2013 ◽  
pp. 1-3 ◽  
Author(s):  
Idit Melnik ◽  
Michal Lotem ◽  
Boris Yoffe
Keyword(s):  
Lymph Node ◽  
Brain Metastases ◽  
Metastatic Melanoma ◽  
Neoadjuvant Therapy ◽  
Tumor Necrosis ◽  
Neoadjuvant Treatment ◽  
Melanoma Metastases ◽  
Excisional Surgery ◽  
Complete Tumor

Vemurafenib is approved by the FDA for the management of unresectable or metastatic melanoma. However, its role as a neoadjuvant therapy has not been determined. We present the first documented case in which vemurafenib induced complete tumor necrosis of both lymph node and brain metastases within one month or less, an outcome that indicated that the patient was a good candidate for excisional surgery.

Brain tumor growth and response to chemotherapy in the subrenal capsule assay

1983 ◽  
Vol 106 (3) ◽  
pp. 229-233 ◽  
Author(s):  
Michael Weizs�cker ◽  
Akihito Nagamune ◽  
Karl Rathmer ◽  
Wolfgang Wechsler
Keyword(s):  
Brain Tumor ◽  
Tumor Growth ◽  
Subrenal Capsule Assay ◽  
Response To Chemotherapy ◽  
Subrenal Capsule

Cutaneous adverse events: a predictor of tumour response under anti‐ PD ‐1 therapy for metastatic melanoma, a cohort analysis of 189 patients

2020 ◽  
Vol 34 (9) ◽  
pp. 2096-2105 ◽  
Author(s):  
L. Bottlaender ◽  
M. Amini‐Adle ◽  
D. Maucort‐Boulch ◽  
P. Robinson ◽  
L. Thomas ◽  
...  
Keyword(s):  
Adverse Events ◽  
Metastatic Melanoma ◽  
Cohort Analysis ◽  
Tumour Response

Lymphocyte subsets during cytostatic + interferon therapy of metastatic melanoma

1993 ◽  
Vol 3 (1) ◽  
pp. 75
Author(s):  
T. Muhonen ◽  
M. Hahka-Kemppinen ◽  
S. Pakkala ◽  
S. Pyrhönen
Keyword(s):  
Metastatic Melanoma ◽  
Interferon Therapy ◽  
Lymphocyte Subsets
Sign in / Sign up

Export Citation Format

Share Document